DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Cameron D, Brown J, Dent R.
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial.
Lancet Oncol 2013;
14: 933-942
We do not assume any responsibility for the contents of the web pages of other providers.